检索结果 - Bin‐Yan Zhong

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

    Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma 由 Bin‐Yan Zhong, Zhi‐Cheng Jin, Jian-Jia Chen, Hai‐Dong Zhu, Xiaoli Zhu

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells

    Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells 由 Stephen G. Patterson, Sheng Wei, X Chen, David A. Sallman, Danielle L. Gilvary, Bin‐Yan Zhong, Julio M. Pow‐Sang, T. Yeatman, J Y Djeu

    出版 2006
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO)

    Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplin... 由 Jian Lü, Ming Zhao, Yasuaki Arai, Bin‐Yan Zhong, Hai‐Dong Zhu, Xiaolong Qi, Thierry de Baère, Uei Pua, Hyun‐Ki Yoon, David C. Madoff, Gao‐Jun Teng

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response

    Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Re... 由 Fei Yang, Guili Xu, Jintao Huang, Yu Yin, Wei Xiang, Bin‐Yan Zhong, Wan-Ci Li, Jian Shen, Shuai Zhang, Jun Yang, Hong Peng Sun, Wansheng Wang, Xiaoli Zhu

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

    Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 由 Xiangpan Meng, Yuancheng Wang, Shenghong Ju, Chun‐Qiang Lu, Bin‐Yan Zhong, Cai‐Fang Ni, Qi Zhang, Qian Yu, Jian Xu, Jiansong Ji, Xiuming Zhang, Tianyu Tang, Guanyu Yang, Ziteng Zhao

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study

    Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembol... 由 Zhi‐Cheng Jin, Li Chen, Bin‐Yan Zhong, Hai-Feng Zhou, Hai‐Dong Zhu, Hai Ying Zhou, Jingjing Song, Jin‐He Guo, Xiaoli Zhu, Jiansong Ji, Cai‐Fang Ni, Gao‐Jun Teng

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study

    Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study 由 Zhi‐Cheng Jin, Bin‐Yan Zhong, Jian-Jia Chen, Hai‐Dong Zhu, Jun‐Hui Sun, Guowen Yin, Naijian Ge, Biao Luo, Wen‐Bin Ding, Wenhui Li, Li Chen, Yu-Qing Wang, Xiaoli Zhu, Yang Weizhu, H. Li, Gao‐Jun Teng

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

    Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment... 由 Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu, Xuhua Duan, Yujing Xin, Bin‐Yan Zhong, Jinzhang Chen, Jun Tie, Kangshun Zhu, Lan Zhang, Ming Huang, Mingjian Piao, Xiao Li, Hai‐Bin Shi, Ruibao Liu, Aibing Xu, Fanpu Ji, Jianbing Wu, Guoliang Shao, H. Li, Mingsheng Huang, Zhiyi Peng, Jiansong Ji, Chunwang Yuan, Xiufeng Liu, Zhou-Chao Hu, Yang Weizhu, Guowen Yin, Jinhua Huang, Naijian Ge, Xiaolong Qi, Yang Zhao, Jiawei Zhou, Guohui Xu, Qiang Tu, Hailan Lin, Yaojun Zhang, Hua Jiang, Haibo Shao, Yong-Jie Su, Tingsong Chen, Baoqi Shi, Xiang Zhou, Haitao Zhao, Hai‐Dong Zhu, Zhenggang Ren, Gao‐Jun Teng

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

    Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) 由 Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang, Yang Weizhu, Guowen Yin, Bin‐Yan Zhong, Jun‐Hui Sun, Zhi‐Cheng Jin, Jian-Jia Chen, Naijian Ge, Wen‐Bin Ding, Wenhui Li, Jinhua Huang, Wei Mu, Shanzhi Gu, Jiaping Li, Hui Zhao, Wen Shu-wei, Yanming Lei, Yusheng Song, Chunwang Yuan, Weidong Wang, Ming Huang, Wei Zhao, Jianbing Wu, Song Wang, Xu Zhu, Jianjun Han, Weixin Ren, Zaiming Lu, Wenge Xing, Yong Fan, Hailan Lin, Zishu Zhang, Guohui Xu, Wenhao Hu, Qiang Tu, Hongying Su, Chuansheng Zheng, Yong Chen, Xuya Zhao, Zhu-ting Fang, Qi Wang, Jinwei Zhao, Aibing Xu, Jian Xu, Qinghua Wu, Huanzhang Niu, Jian Wang, Feng Dai, Duiping Feng, Qingdong Li, Rong-Shu Shi, Jiarui Li, Guang Yang, Hai‐Bin Shi, Jiansong Ji, Yue Liu, Zheng Cai, Po Song Yang, Yang Zhao, Xiaoli Zhu, Ligong Lu, Gao‐Jun Teng

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: